BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38246221)

  • 1. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
    Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma.
    Li W; Huang Q; Peng Y; Pan S; Hu M; Wang P; He Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15923-15938. PubMed ID: 37673824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance.
    Zheng K; Hai Y; Xi Y; Zhang Y; Liu Z; Chen W; Hu X; Zou X; Hao J
    J Transl Med; 2023 Nov; 21(1):789. PubMed ID: 37936202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy.
    Xing X; Hu E; Ouyang J; Zhong X; Wang F; Liu K; Cai L; Zhou Y; Wang Y; Chen G; Li Z; Wu L; Liu X
    Cell Rep Med; 2023 Dec; 4(12):101315. PubMed ID: 38091986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of T-cell exhaustion-related gene signature for predicting prognosis in glioblastoma multiforme.
    Liu YH; Jin HQ; Liu HP
    J Cell Mol Med; 2023 Nov; 27(22):3503-3513. PubMed ID: 37635346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
    Cai D; Liu T; Fang J; Liu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
    Liu Z; Xu H; Weng S; Ren Y; Han X
    Front Immunol; 2022; 13():828330. PubMed ID: 35154148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HISMD: A Novel Immune Subtyping System for HNSCC.
    Yang D; Wu Y; Wan Z; Xu Z; Li W; Yuan P; Shang Q; Peng J; Tao L; Chen Q; Dan H; Xu H
    J Dent Res; 2023 Mar; 102(3):270-279. PubMed ID: 36333876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunometabolism subtyping system identifies S100A9
    Bao X; Wang D; Dai X; Liu C; Zhang H; Jin Y; Tong Z; Li B; Tong C; Xin S; Li X; Wang Y; Liu L; Zhu X; Fu Q; Zheng Y; Deng J; Tian W; Guo T; Zhao P; Chen W; Fang W
    Cell Rep Med; 2023 Apr; 4(4):100987. PubMed ID: 36990096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-DCC: decoupled contrastive clustering method for cancer subtype identification based on multi-omics data.
    Zhao J; Zhao B; Song X; Lyu C; Chen W; Xiong Y; Wei DQ
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36702755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer subtyping with heterogeneous multi-omics data via hierarchical multi-kernel learning.
    Wei Y; Li L; Zhao X; Yang H; Sa J; Cao H; Cui Y
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36433785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical Methods for Integrative Clustering of Multi-omics Data.
    Chalise P; Kwon D; Fridley BL; Mo Q
    Methods Mol Biol; 2023; 2629():73-93. PubMed ID: 36929074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated multi-omics characterization of KRAS mutant colorectal cancer.
    Chong W; Zhu X; Ren H; Ye C; Xu K; Wang Z; Jia S; Shang L; Li L; Chen H
    Theranostics; 2022; 12(11):5138-5154. PubMed ID: 35836817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
    Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
    Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.
    Xia F; Yu Z; Deng A; Gao G
    Exp Biol Med (Maywood); 2022 Feb; 247(3):246-262. PubMed ID: 34743576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
    Takahashi S; Asada K; Takasawa K; Shimoyama R; Sakai A; Bolatkan A; Shinkai N; Kobayashi K; Komatsu M; Kaneko S; Sese J; Hamamoto R
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33086649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
    Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
    Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer.
    Zeng H; Chen L; Zhang M; Luo Y; Ma X
    Gynecol Oncol; 2021 Oct; 163(1):171-180. PubMed ID: 34275655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.